SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2)

This biosafety advisory is being provided by the Public Health Agency of Canada (PHAC) to assist clinical, diagnostic, and research laboratories in implementing proper biosafety procedures to handle samples that may contain SARS-CoV-2.

Données et ressources

Info additionnelle

Champ Valeur
Dernière modification avril 17, 2026, 20:36 (TU)
Créé le avril 17, 2026, 20:36 (TU)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2020-02-29 00:00:00
open_canada_keywords {"fr": ["SARS-CoV-2", "avis de biosécurité", "laboratoires cliniques", "de disagnostic et de recherche"], "en": ["SARS-CoV-2", "Biosafety advisory", "clinical", "diagnostic", "and research laboratories."]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2 pour Coronavirus du syndrome respiratoire aigu sévère 2)
update_frequency as_needed